[Microvascular angina].
Katagiri
Takashi
T
Third Department of Internal Medicine, Showa University School of Medicine.
Suzuki
Hiroshi
H
Takeyama
Youichi
Y
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D017023:Coronary Angiography; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D008833:Microcirculation / Q000473:pathology / Q000503:physiopathology; D017566:Microvascular Angina / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control; D009574:Nitro Compounds / Q000627:therapeutic use; D011379:Prognosis; D014664:Vasodilation
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D002121:Calcium Channel Blockers; D009574:Nitro Compounds